A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer-Reference-Cited by-同舟云学术

A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer

Published:2017-04-27 Issue:4 Volume:12 Page:e0176525
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Inoue Yoshiaki,Shiihara Jun,Miyazawa Hitoshi,Ohta Hiromitsu,Higo Megumi,Nagai Yoshiaki,Kobayashi Kunihiko,Saijo Yasuo,Tsuchida Masanori,Nakayama Mitsuo,Hagiwara Koichi

Funder

Ministry of Health, Labor, and Welfare, Japan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;M Maemondo;N Engl J Med,2010

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;T Mitsudomi;Lancet Oncol,2010

3. Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC);K Kobayashi;Target Oncol,2013

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;TJ Lynch;N Engl J Med,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;JG Paez;Science,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features;Virchows Archiv;2024-05-06

2. Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation;Clinical Lung Cancer;2024-01

3. Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial;Cancer Science;2023-05-03

4. Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer;Heliyon;2023-03

5. Utilization of Cytological Specimens for the Mutation Test in Lung Cancer;Nihon Naika Gakkai Zasshi;2023-01-10